|
1
|
Wolf K and Friedl P: Mapping proteolytic
cancer cell-extracellular matrix interfaces. Clin Exp Metastasis.
26:289–298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chakraborti S, Mandal M, Das S, Mandal A
and Chakraborti T: Regulation of matrix metalloproteinases: an
overview. Mol Cell Biochem. 253:269–285. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malemud CJ: Matrix metalloproteinases
(MMPs) in health and disease: an overview. Front Biosci.
11:1696–1701. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
VanSaun MN and Matrisian LM: Matrix
metalloproteinases and cellular motility in development and
disease. Birth Defects Res C Embryo Today. 78:69–79. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson CL and Matrisian LM: Matrilysin: an
epithelial matrix metalloproteinase with potentially novel
functions. Int J Biochem Cell Biol. 28:123–136. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu Z, Wang Y, Zhang Q, et al: Association
between the functional polymorphism in the matrix
metalloproteinase-7 promoter and susceptibility to adult
astrocytoma. Brain Res. 1118:6–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Beeghly-Fadiel A, Long JR, Gao YT, et al:
Common MMP-7 polymorphisms and breast cancer susceptibility: a
multistage study of association and functionality. Cancer Res.
68:6453–6459. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Woolf B: On estimating the relation
between blood group and disease. Ann Hum Genet. 19:251–253. 1955.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cochran WG: The combination of estimates
from different experiments. Biometrics. 10:101–129. 1954.
View Article : Google Scholar
|
|
11
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
12
|
DerSimonian R and Kacker R: Random-effects
model for meta-analysis of clinical trials: an update. Contemp Clin
Trials. 28:105–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malik MA, Zargar SA and Mittal B: Role of
the metalloproteinase-7 (181A>G) polymorphism in gastric cancer
susceptibility: a case control study in Kashmir valley. Asian Pac J
Cancer Prev. 12:73–76. 2011.
|
|
15
|
Malik MA, Sharma KL, Zargar SA and Mittal
B: Association of matrix metalloproteinase-7 (-181A>G)
polymorphism with risk of esophageal squamous cell carcinoma in
Kashmir Valley. Saudi J Gastroenterol. 17:301–306. 2011.
|
|
16
|
Sugimoto M, Furuta T, Kodaira C, et al:
Polymorphisms of matrix metalloproteinase-7 and chymase are
associated with susceptibility to and progression of gastric cancer
in Japan. J Gastroenterol. 43:751–761. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dziki L, Przybylowska K, Majsterek I,
Trzcinski R, Mik M and Sygut A: A/G polymorphism of the MMP-7 gene
promoter region in colorectal cancer. Pol Przegl Chir. 83:622–626.
2011.PubMed/NCBI
|
|
18
|
Fang WL, Liang WB, He H, et al:
Association of matrix metalloproteinases 1, 7, and 9 gene
polymorphisms with genetic susceptibility to colorectal carcinoma
in a Han Chinese population. DNA Cell Biol. 29:657–661. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Srivastava P, Gangwar R, Kapoor R and
Mittal RD: Bladder cancer risk associated with genotypic
polymorphism of the matrix metalloproteinase-1 and 7 in North
Indian population. Dis Markers. 29:37–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lievre A, Milet J, Carayol J, et al:
Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk
of colorectal adenoma. BMC Cancer. 6:2702006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yi YC, Chou PT, Chen LY, et al: Matrix
metalloproteinase-7 (MMP-7) polymorphism is a risk factor for
endometrial cancer susceptibility. Clin Chem Lab Med. 48:337–344.
2010.PubMed/NCBI
|
|
22
|
Singh H, Jain M and Mittal B: MMP-7
(-181A>G) promoter polymorphisms and risk for cervical cancer.
Gynecol Oncol. 110:71–75. 2008.
|
|
23
|
Qiu W, Zhou G, Zhai Y, et al: No
association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk
of hepatocellular carcinoma in a Chinese population. Cancer
Epidemiol Biomarkers Prev. 17:2514–2518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohtani H, Maeda N and Murawaki Y:
Functional polymorphisms in the promoter regions of matrix
metalloproteinase-2, -3, -7, -9 and TNF-alpha genes, and the risk
of colorectal neoplasm in Japanese. Yonago Acta Medica. 52:47–56.
2009.
|
|
25
|
Woo M, Park K, Nam J and Kim JC: Clinical
implications of matrix metalloproteinase-1, -3, -7, -9, -12, and
plasminogen activator inhibitor-1 gene polymorphisms in colorectal
cancer. J Gastroenterol Hepatol. 22:1064–1070. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang J, Jin X, Fang S, et al: The
functional polymorphism in the matrix metalloproteinase-7 promoter
increases susceptibility to esophageal squamous cell carcinoma,
gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Carcinogenesis. 26:1748–1753. 2005. View Article : Google Scholar
|
|
27
|
Ghilardi G, Biondi ML, Erario M,
Guagnellini E and Scorza R: Colorectal carcinoma susceptibility and
metastases are associated with matrix metalloproteinase-7 promoter
polymorphisms. Clin Chem. 49:1940–1942. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
de Lima JM, de Souza LG, da Silva ID and
Forones NM: E-cadherin and metalloproteinase-1 and -7 polymorphisms
in colorectal cancer. Int J Biol Markers. 24:99–106.
2009.PubMed/NCBI
|
|
29
|
Li Y, Jin X, Kang S, et al: Polymorphisms
in the promoter regions of the matrix metalloproteinases-1, -3, -7,
and -9 and the risk of epithelial ovarian cancer in China. Gynecol
Oncol. 101:92–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li JY, Tian M and Zhao A: Polymorphism in
the promoter region of the metalloproteinase-7 increases
susceptibility and risk of metastasis of gastric adenocarcinoma.
Gastroenterology. 134:A6032008.
|
|
31
|
Tao HJ, Wu SH, Zhang L, et al: Correlation
of polymorphism of IL-8 and MMP-7 genes with the risk of early
stage cervical cancer in Shanxi. Chin Remedies and Clinics.
10:852–854. 2010.
|
|
32
|
Zhang Y, Du H, Kang S, Sun DL and Li Y:
Association of SNP in matrix metalloproteinase-7 polymorphism with
susceptibility of ovarian cancer. China J Mod Med. 20:2792–2798.
2010.
|
|
33
|
Yao N: Correlation of polymorphism of
MMP-7 gene with the risk of early stage cervical cancer. China J
Modern Med. 21:3519–3521. 2011.(In Chinese).
|
|
34
|
Kubben FJ, Sier CF, Meijer MJ, et al:
Clinical impact of MMP and TIMP gene polymorphisms in gastric
cancer. Br J Cancer. 95:744–751. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vairaktaris E, Serefoglou Z, Yapijakis C,
et al: High gene expression of matrix metalloproteinase-7 is
associated with early stages of oral cancer. Anticancer Res.
27:2493–2498. 2007.PubMed/NCBI
|
|
36
|
Wu S, Lu S, Tao H, et al: Correlation of
polymorphism of IL-8 and MMP-7 with occurrence and lymph node
metastasis of early stage cervical cancer. J Huazhong Univ Sci
Technolog Med Sci. 31:114–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
